Mr. Dickey combines experience in entrepreneurial management with a background in capital markets, transaction structuring and merger and acquisitions (M&A). He is a Managing Director of DSS Partners LLC, an entity engaged in acquiring or in-licensing promising drug candidates and providing hands-on financial and technical management for their development.

Mr. Dickey joined an oncology-focused drug development company, Protarga, in 1996 as its fourth employee, first as CFO, and then in 2003 as its President, CEO and CFO. During this period, the company advanced from discovery stage to 60 employees and a new cancer drug in pivotal Phase III clinical studies. He raised $57 million privately for Protarga and oversaw its subsequent sale to Sankyo, the second largest pharmaceutical company in Japan.

Before joining Protarga, Mr. Dickey spent seventeen years as an investment banker, where he was involved in public and private offerings of debt and equity and in mergers and acquisitions for entrepreneurially-based companies as well as Fortune 100 corporations. For the four years prior to joining Protarga, Mr. Dickey was a Managing Director in the corporate finance department at Legg Mason Wood Walker. Before that he spent thirteen years at Lehman Brothers in New York, lastly as a Senior Vice President in its M&A Department and then as a founder and partner in its middle market investment banking group affiliate.

Mr. Dickey received a B.A. from Princeton University and an M.B.A. from The Wharton School, University of Pennsylvania.